TACR1 and cancer: SP also has an oncogenic function through the activation of NK1R, or directly, through effects derived from the constitutive activation of the NK1R receptor, such as inducing mitogenic pathways and sustaining proliferative signalling through the activation of the PI3K and MAPK oncogenic pathways [8,9,10,11,12], itself the canonical and most representative hallmark of cancer.